Article

Learning from New Zealand During Coronavirus

Author(s):

How the island nation has set an efficient model of care access and preparation that has allowed them to best manage COVID-19.

The US has reached 644,000 cases of coronavirus 2019 (COVID-19) this week, with no area facing a greater brunt of the pandemic than New York City—nearly 1 in every 5 confirmed cases have come from the city.

As the virus has spread gradually from its origin in China, country leaders and responders have used preparation time to share difficulties, new research, and best practices among each other. The systems of some countries, though, have proven more capable in helping manage the virus from the start. The lessons learned from these countries may be greater than just particular care of COVID-19.

In an interview with HCPLive®, Dr. David Rapoport, Director of the Sleep Medicine Research Program and Professor of Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai, corresponded from his stay in New Zealand during a remote program which began just prior to the COVID-19 spread.

As of April 15, New Zealand had reported just 1084 confirmed COVID-19 cases—770 (71%) of which had patients who were confirmed recovered—and just 9 deaths. Rapoport discussed the infrastructure of the New Zealand public health response agencies, their role in assisting at-need neighboring regions, and what lessons nations like the US could take from their inherent capability in pandemic response.

Related Videos
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Discussing Use of Vaping Among Students, Conversations About Vaccines
Pavel Strnad, MD | Credit: RWTH Aachen
© 2024 MJH Life Sciences

All rights reserved.